Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023

Penumbra, Inc. (NYSE: PEN) has scheduled a conference call to discuss its fourth quarter and full year 2022 financial results on February 23, 2023, at 4:30 PM Eastern Time.

Rhea-AI Summary

Penumbra, Inc. (NYSE: PEN) has scheduled a conference call to discuss its fourth quarter and full year 2022 financial results on February 23, 2023, at 4:30 PM Eastern Time. A press release detailing the results will be issued after market close that same day. The call will be accessible via phone or a webcast on the company's website, with a recording available for two weeks after the event. Penumbra focuses on innovative medical therapies and supports healthcare providers globally.

Argus Session date unavailable

+2.40% session move Open Argus

Details

News Market Reaction – PEN

The recorded move for PEN in the trading session of this news was +2.40%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALAMEDA, Calif., Jan. 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 after market close on Thursday, February 23, 2023 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2022 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Source: Penumbra, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call-for-february-23-2023-301728563.html

SOURCE Penumbra, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Penumbra release its fourth quarter and full year 2022 results?

Penumbra will release its fourth quarter and full year 2022 results on February 23, 2023.

How can I access Penumbra's conference call for financial results?

You can access the conference call by dialing (888) 330-2443 or through the webcast on Penumbra's website.

What is the purpose of Penumbra's conference call on February 23, 2023?

The purpose is to discuss the financial results for the fourth quarter and full year 2022.

What time does the Penumbra conference call start on February 23, 2023?

The conference call starts at 4:30 PM Eastern Time.

Will the conference call be available for replay?

Yes, the webcast will be available for at least two weeks following the call.